Wanbury Limited — Others, 26-08-2025: Shareholders meeting

Wanbury Limited has announced its 37th Annual General Meeting on September 18, 2025, for the adoption of financial results. For FY25, total revenue reached ₹599.51 Cr with a net profit of ₹30.53 Cr. The API division saw 3% revenue growth to ₹530 Cr, driven by Sertraline and Tramadole. Domestic formulations grew 17% to ₹66.28 Cr. Key proposals include re-appointing Mr. Mohan Kumar Rayana and appointing Mr. Chandran Krishnamoorthy as Whole-time Director for five years, with remuneration updates. The company is altering its Articles of Association, removing outdated clauses. It recently raised ₹175 Cr through unlisted non-convertible debentures for financing needs. No dividend has been declared for FY25.